Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Pain acts through fatigue to affect participation in individuals with multiple sclerosis.
Metabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control study.
The temporal dynamics of visual processing in multiple sclerosis.
Duloxetine for the Treatment of Overactive Bladder Syndrome in Multiple Sclerosis: A Pilot Study.
Bilateral hypogeusia caused by a small lesion in the lower midbrain tegmentum.
Neuroprotection and repair in multiple sclerosis.
S1P and the birth of platelets.
Switching and escalating therapy in long-lasting multiple sclerosis: not always necessary.
Peripheral blood mononuclear cell membrane fluidity and disease outcome in patients with multiple sclerosis.
Natural history of multiple sclerosis symptoms.
MSX3 Switches Microglia Polarization and Protects from Inflammation-Induced Demyelination.
Role of a novel HLA-DQA1*01:02;DRB1*15:01 mixed-isotype heterodimer in the pathogenesis of 'humanized' multiple sclerosis-like disease.
Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study.
[Cognitive Impairment in Multiple Sclerosis].
Human pluripotent stem cell-derived neural constructs for predicting neural toxicity.
Chronic Inflammatory Demyelinating Polyneuropathy Manifesting as Neuropathy With Liability to Pressure Palsies: A Case Report.
Except for C-C chemokine receptor 7 expression, monocyte-derived dendritic cells from patients with multiple sclerosis are functionally comparable to those of healthy controls.
Depressive Symptoms in Multiple Sclerosis from an In Vivo Study with TBSS.
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE.
Social participation in patients with multiple sclerosis: correlations between disability and economic burden.
Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter.
Naturally Occurring Antibodies as Therapeutics for Neurologic Disease : Can Human Monoclonal IgMs Replace the Limited Resource IVIG?
White matter disease: Hyaluronidase PH-20 digestion products inhibit remyelination in demyelinating lesions.
Brain abnormalities in neuromyelitis optica spectrum disorder.
Targeting cells in motion: migrating toward improved therapies.

Pages